Evidence map›Paper›PMID 35741746›Full record

ArticleGenes2022

Transcriptome Analysis of

Hedong Lu, Hai Xu, Panping Yang, Muhammad Bilal, Shaohui Zhu, Mengyuan Zhong, Li Zhao, Chengyuan Gu, Shuai Liu, Yuping Zhao and 1 more

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Genes, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
3.4field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Antimicrobial Activity ofInternational journal of molecular sciences · 2025
    Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Article
  9. Complete genome sequencing ofCurrent research in microbial sciences · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Hedong LuSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian 223003, China.
Hai XuSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian 223003, China.
Panping YangSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian 223003, China.
Muhammad BilalSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian 223003, China.ORCID 0000-0001-5388-3183
Shaohui ZhuSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian 223003, China.
Mengyuan ZhongSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian 223003, China.ORCID 0000-0002-3578-1658
Li ZhaoSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian 223003, China.
Chengyuan GuSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian 223003, China.
Shuai LiuSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian 223003, China.
Yuping ZhaoSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian 223003, China.
Chengxin GengSchool of Life Science and Food Engineering, Huaiyin Institute of Technology, Huaian 223003, China.
Huaiyin Institute of Technology · CNJiangnan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Fengycin is a lipopeptide produced by

Indexed as

Bacillus amyloliquefaciensFructoseGene Expression ProfilingLipopeptidesfengycinFructoseLipopeptidesBacillus amyloliquefaciensfengycinmetabolismregulationtranscriptomic

Identifiers

PMID35741746
PMCPMC9222730
OpenAlexW4281747079

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.